Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nevis Brands Inc C.NEVI

Alternate Symbol(s):  NEVIF

Nevis Brands Inc., formerly Pascal Biosciences Inc., provides cannabis brands throughout the United States. The Company provides products in Washington, Oregon, California, Ohio, Arizona and Colorado through partners and licensees. Its products include Major, which is a cannabis beverage. Major is a high-dose tetrahydrocannabinol (THC) beverage that delivers a consistent cannabis experience with no cannabis taste or smell. Major offers various flavors, such as volcanic orange mango, sunset pink lemonade, pacific coast blue raspberry, dreamin' of passion, and sacred grape. It also offers Major Minis, which is a smaller 2 ounce (oz) shot. Major Minis comes in three flavors, such as blueberry, fruit punch, and blackberry lemonade.


CSE:NEVI - Post by User

Bullboard Posts
Comment by EarlyInvestor59on Mar 18, 2018 3:03pm
310 Views
Post# 27736150

RE:RE:RE:Conformation closure on NR on PP......IS coming soon.

RE:RE:RE:Conformation closure on NR on PP......IS coming soon.

Hi there,
 

After talking with the management last week, I got VERY reassured about what's upcomming.
 

First, they are looking for partners in term of expanding the research and getting deeper in the discovery (pharmaceutical and pharmacological partners)
 

On top of it, they are looking with pharmaceutical/transformation firms in order to isolate in soft gel the molecules in order to start the clinical trial. This is very positive

Finally, they are in talk with licensed producers to see if they could get very stable and mix of strains in order to test different pathology. A joint-venture is far from excluded at this stage. They are in talk with it but they are concerned about their vision of the research being alterated by such partnership....Very nice pipeline also
 

This is very very promising
 

I wound't be suprise if this stock pop's to 2-3$ in no time on a single news. We are talking about not diminishing the cancer effect here. We are talking about SOLVING the cancer.. I think it's huge.
 

Still, a spec play but very good team in place. They are not business, they are scientifics. This is why maybe they are not sharp on promoting the stock wisely but we don't care. As long as they move forward with that discovery the potential of this going in multi hundred millions market caps is very likely
 

Cheers

Bullboard Posts